Cambridge Investment Research Advisors »

Cue Biopharma shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $42k 22k 1.89
2023-12-31 $59k 22k 2.66
2023-09-30 $51k 22k 2.30
2023-06-30 $73k 20k 3.65

More positions owned by Cambridge Investment Research Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Inc Com (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Microsoft Corp Com (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
SPDR S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Vanguard Index Fds Value Etf (VTV)

View all positions for Cambridge Investment Research Advisors

Top funds holding Cue Biopharma

Vanguard Group
Bleichroeder
Robertson Stephens Wealth Management
Dimensional Fund Advisors
Monaco Asset Management SAM
Millennium Management
Bank of America Corporation
Sigma Planning
GSA Capital Partners
Stifel Financial
Charles Schwab Investment Management
Good Life Advisors
UBS Group
Bank of New York Mellon
HighTower Advisors

View all funds holding Cue Biopharma